课题基金 / 基金详情

Tryptase - PAR2 axis involved in urinary voiding dysfunction

Tryptase - PAR2 axis involved in urinary voiding dysfunction
类胰蛋白酶 - PAR2 轴参与排尿功能障碍
批准号:
8836158
负责人:
Kenny M Roman
金额:
$5.36万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-01 至 2017-11-30

项目摘要

项目成果

Kenny M Roman的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)是一种多症状的临床问题,涉及持续3个月以上的疼痛并导致排尿功能障碍。由于对其病因和发病机制的不完全了解,治疗方案很少。我们实验室进行的研究表明,蛋白酶激活受体2 (PAR2)的肥大细胞胰蛋白酶激活与实验性自身免疫性前列腺炎(EAP)小鼠的慢性盆腔疼痛直接相关,EAP是一种模仿CP/CPPS方面的小鼠模型。然而,迄今为止,typase - par2轴尚未被探索作为CP/CPPS患者报告的泌尿系统症状的潜在介质。该研究项目旨在研究胰蛋白酶- par2轴与CP/CPPS小鼠模型排尿功能障碍之间的联系。初步研究表明,PAR2可能参与排尿功能障碍。简而言之,数据显示EAP小鼠尿频增加。此外,EAP小鼠的前列腺α -平滑肌肌动蛋白(a- sma)表达增加,这是一种纤维化标志物。相比之下,PAR2敲低(KO)与EAP没有显示尿频的变化,前列腺没有显示a-SMA表达的变化。此外,我们报道了由于PAR2激活导致背根神经节致敏在EAP小鼠中发生,这表明前列腺和膀胱之间的跨器官致敏可能导致泌尿系统症状。根据初步数据,我们假设肥大细胞胰蛋白酶- par2轴是前列腺纤维化和致敏性导致膀胱功能障碍的新调节剂。拟开展的研究项目将通过以下具体目标来解决这一假设:1)确定前列腺中胰蛋白酶PAR2的激活对膀胱功能障碍的作用;2)确定胰蛋白酶-PAR2轴对前列腺和膀胱共有DRG中跨器官致敏的影响。总的来说,这些结果将阐明我们对CP/CPPS患者泌尿系统症状诱导的理解,并确定治疗排尿功能障碍的新治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a multi-symptomatic clinical problem that involves pain lasting more than 3 months and leads to urinary voiding dysfunction. There are few therapeutic options due to an incomplete understanding of its etiology and pathogenesis. Studies conducted in our laboratory revealed that mast-cell tryptase activation of protease-activated receptor 2 (PAR2) is directly linked to chronic pelvic pain in mice with experimental autoimmune prostatitis (EAP), a mouse model that mimics aspects of CP/CPPS. However, to date, the typtase-PAR2 axis has not been explored as a potential mediator of urinary symptoms reported by CP/CPPS patients. The proposed research project seeks to investigate the link between tryptase-PAR2 axis and urinary voiding dysfunction in a mouse model of CP/CPPS. Preliminary studies presented in this research proposal revealed that PAR2 may be involved in urinary voiding dysfunction. Briefly, data showed that mice with EAP have increased urinary frequency. Also, the prostate of mice with EAP have increased expression of alpha-smooth muscle actin (a-SMA), a fibrosis marker. In contrast, PAR2 knockdown (KO) with EAP do not show changes to urinary frequency and the prostate showed no change in a-SMA expression. In addition, we report that sensitization of dorsal root ganglia due to PAR2 activation occurs in mice with EAP, suggesting that cross-organ sensitization between the prostate and bladder may lead to urinary symptoms. Based on the preliminary data we hypothesize that the mast cell tryptase-PAR2 axis is a novel regulator of prostate fibrosis and sensitization that leads to bladder dysfunction. The proposed research project will address the hypothesis using the following specific aims: 1) Determine the role of tryptase activation of PAR2 in the prostate on bladder dysfunction and 2) determine the effect of the tryptase-PAR2 axis on cross-organ sensitization in DRG shared by the prostate and bladder. Overall, the results from these aims will elucidate our understanding of the induction of urinary symptoms in CP/CPPS patients and identify a novel therapeutic target for treating urinary voiding dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transition from Acute to Chronic Pelvic Pain in a Murine Model of Chronic Prostatitis
Transition from Acute to Chronic Pelvic Pain in a Murine Model of Chronic Prostatitis
Transition from Acute to Chronic Pelvic Pain in a Murine Model of Chronic Prostatitis
Transition from Acute to Chronic Pelvic Pain in a Murine Model of Chronic Prostatitis
海外基金